Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small-cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05801107
What this trial is testing

Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06902272
What this trial is testing

CtDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Miami 30
Large-scale testing (Phase 3)UnknownNCT01014130
What this trial is testing

Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Trans Tasman Radiation Oncology Group 101
Large-scale testing (Phase 3)Study completedNCT00243867
What this trial is testing

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
American Regent, Inc. 518
Testing effectiveness (Phase 2)Study completedNCT01116219
What this trial is testing

Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).

Who this might be right for
Lung Cancer
Swiss Cancer Institute 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT04919811
What this trial is testing

Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Nuvation Bio Inc. 217
Early research (Phase 1)Study completedNCT01684111
What this trial is testing

An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Aktion Bronchialkarzinom e.V. 7
Testing effectiveness (Phase 2)Looking for participantsNCT05398094
What this trial is testing

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage IIIKRAS P.G12C
Fundación GECP 19
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Not applicableStudy completedNCT00277082
What this trial is testing

Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung

Who this might be right for
Corpus UteriLung Cancer
University of New Mexico 24
Early research (Phase 1)Not Yet RecruitingNCT06585059
What this trial is testing

Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers

Who this might be right for
Advanced Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT03293680
What this trial is testing

Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 83
Not applicableStudy completedNCT00351962
What this trial is testing

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Who this might be right for
Lung NeoplasmsLung Cancer
AHS Cancer Control Alberta 58
Testing effectiveness (Phase 2)Study completedNCT00157209
What this trial is testing

Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck KGaA, Darmstadt, Germany 171
Not applicableStudy completedNCT04676321
What this trial is testing

Key Performance Indicators for the Assessment of NSCLC Patients Pathway

Who this might be right for
Non Small Cell Lung Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 430
Not applicableStudy completedNCT07267247
What this trial is testing

Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (MeSH Term: Carcinoma, Non-Small-Cell Lung)Drug-Related Side Effects and Adverse Reactions (MeSH Term)Egfr Tyrosine Kinase Inhibitor+1 more
Taichung Veterans General Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472647
What this trial is testing

SYS6090 Combination Therapy in Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung Cancer
Shanghai JMT-Bio Inc. 596
Testing effectiveness (Phase 2)Study completedNCT00743938
What this trial is testing

A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Bristol-Myers Squibb 141
Large-scale testing (Phase 3)Looking for participantsNCT06899126
What this trial is testing

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Daiichi Sankyo 686
Early research (Phase 1)Active Not RecruitingNCT03807778
What this trial is testing

Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Takeda 53
Next Page